Understand the source comparison
SLU-PP-332 Exercise Mimetic vs AICAR vs GW501516: Mechanism Comparison
Before using SLU-PP-332 for an exercise mimetic protocol, understanding how it differs from earlier-generation compounds clarifies why protocol structure matters. SLU-PP-332 ERRα/ERRγ agonist. Directly activates transcription factors for mitochondrial biogenes
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before using SLU-PP-332 for an exercise mimetic protocol, understanding how it differs from earlier-generation compounds clarifies why protocol structure matters.
- SLU-PP-332
- ERRα/ERRγ agonist. Directly activates transcription factors for mitochondrial biogenesis
- PGC-1α upregulation, mitochondrial biogenesis, fatty acid oxidation
- 70% increase in running time after 28 days (10mg/kg daily)
- Daily (short half-life, 4–6 hours)
- None. Purely metabolic
- Most selective for oxidative adaptation without off-target effects; no mechanical load adaptation
- AICAR
- AMPK activator. Mimics low cellular energy state
- AMPK pathway, glucose uptake, glycolysis
- 44% increase in running time after 28 days (500mg/kg daily)
- Daily (requires high dose for effect)
- None
- Broad metabolic activation but less specific; higher doses needed; significant off-target effects on cardiac tissue
- GW501516
- PPARδ agonist. Shifts muscle fiber type toward oxidative
- Fatty acid oxidation, Type I muscle fiber conversion
- 68% increase in running time after 21 days (10mg/kg daily)
- Daily
- Potent endurance effect but carcinogenic in long-term rodent studies; not viable for human use
- Endurance Training (8 weeks)
- Mechanical contraction, energy depletion, lactate signaling
- Multiple. AMPK, PGC-1α, calcium signaling, mechanical stress
- 60–80% improvement in trained vs untrained subjects
- 4–6 sessions/week
- Yes. Bone density, tendon strength, neuromuscular recruitment
- Gold standard; produces metabolic AND structural adaptations that compounds cannot replicate
- SLU-PP-332 sits at the intersection of specificity and efficacy. AICAR works but requires massive doses and hits pathways unrelated to exercise (cardiac AMPK activation can cause arrhythmias at high doses). GW501516 works potently but caused rapidly-progressing cancers in every organ system during two-year rodent studies. It was abandoned for human development in 2007. SLU-PP-332 demonstrates clean ERR selectivity without the off-target organ toxicity that halted earlier mimetics.
- The bottom line: if the goal is isolated metabolic adaptation without structural or neural training effect, SLU-PP-332 is the most refined tool available in 2026. If the goal is comprehensive fitness. Strength, coordination, bone health, tendon resilience. No compound replicates that. Use SLU-PP-332 for exercise mimetic protocols when the research question isolates metabolic pathways, not as a substitute for physical training in any practical context.